UBS faces pay backlash as Weber becomes chairman
ZURICH (Reuters) - UBS became the latest bank to face the anger of its shareholders over executive pay on Thursday, as investors queued up to voice their complaints in a...
Home > Reviews
All Stories
UBS faces pay backlash as Weber becomes chairman
ZURICH (Reuters) - UBS became the latest bank to face the anger of its shareholders over executive pay on Thursday, as investors queued up to voice their complaints in a...
UBS shares jump as private bank proves its appeal
ZURICH (Reuters) - UBS AG posted strong money flows into its flagship private bank on Wednesday, underscoring the Swiss lender's appeal as a haven for the savings of the world's...
UBS shares jump as private bank proves its appeal
ZURICH (Reuters) - UBS AG posted strong money flows into its flagship private bank on Wednesday, underscoring the Swiss lender's appeal as a haven for the savings of the world's...
Credit Suisse suffers pay revolt, Barclays seen next
LONDON/ZURICH (Reuters) - Almost a third of Credit Suisse shareholders rejected the bank's pay plan on Friday and UK rival Barclays was braced for a similar revolt as investors vented...
Credit Suisse and Barclays investors revolt over pay
LONDON/ZURICH (Reuters) - More than a quarter of shareholders at Credit Suisse and Barclays voted down the banks' pay plans on Friday, in a sign investors are catching up with...
Roche to file T-DM1 breast cancer drug on good data
ZURICH (Reuters) - Roche said patients with an aggressive type of breast cancer lived longer after taking its experimental "armed antibody" drug without the disease worsening than those on a...
Roche to file T-DM1 breast cancer drug on good data
ZURICH (Reuters) - Roche said patients with an aggressive type of breast cancer lived longer after taking its experimental "armed antibody" drug without the disease worsening than those on a...